Publikationen, an denen er mitarbeitet Eduardo Castañón (7)

2015

  1. Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis

    Journal of Translational Medicine, Vol. 13, Núm. 1

  2. Safety and efficacy of temsirolimus under compassionate use in heavily pretreated patients with poor-prognosis solid tumors

    Minerva Chirurgica

2014

  1. Epidermal growth factor receptor targeting in non-small cell lung cancer: Revisiting different strategies against the same target

    Current Drug Targets, Vol. 15, Núm. 14, pp. 1273-1283

2013

  1. Clinical management of small-cell carcinoma of the urinary tract: A 10-year single-center's experience

    Clinical Genitourinary Cancer, Vol. 11, Núm. 2, pp. 168-174

  2. Neurological and cytological response as potential early predictors of time-to-progression and overall survival in patients with leptomeningeal carcinomatosis treated with intrathecal liposomal cytarabine: A retrospective cohort study

    Journal of Neuro-Oncology

  3. Safety and efficacy of maintenance therapy with a nonspecific cytochrome P17 inhibitor (CYP17i) after response/stabilization to docetaxel in metastatic castration-resistant prostate cancer

    Clinical Genitourinary Cancer, Vol. 11, Núm. 2, pp. 78-84

2011

  1. EGFR mutation testing in nonsmall cell lung cancer patients by using cytology specimens: When the tissue is no longer the issue

    Cancer Cytopathology